Much of Medtronic’s work in diabetes this year has focused specifically on bringing new technologies to European patients—and its latest purchase continues this trend. The medtech giant snapped up the ...
Of the roughly 1.5 million adverse drug events are reported annually to the FDA, more than half are attributed to infusion-related errors. The automated pumps that ...
DUBLIN--(BUSINESS WIRE)--The "Infusion Pumps and Devices: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. Infusion pumps are widely used in hospitals, ...
An unspecified number of ambulatory infusion pumps were recalled because of nearly 3,700 complaints related to several product issues, the FDA said March 20. InfuTronix voluntarily recalled five types ...
LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global programmable infusion pumps market and the market is poised to grow by USD 487.81 million during 2020-2024 at a CAGR of almost 8% ...
Continuous subcutaneous insulin infusion (CSII) has become an indispensable modality in the management of type 1 diabetes. This therapy employs an insulin pump to deliver both basal and bolus doses, ...
You've probably seen an infusion pump, even though the name might make it sound like a mysterious piece of medical technology. These devices govern the flow of IV medications and fluids into patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results